International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
The DOI matches its Crossref record; 321 of the 321 references it cites were found in a registry or an index.
Abstract
Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A Task Force, supported by the European Respiratory Society and American Thoracic Society, reviewed the definition and provided recommendations and guidelines on the evaluation and treatment of severe asthma in children and adults. A literature review was performed, followed by discussion by an expert committee according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach for development of specific clinical recommendations. When the diagnosis of asthma is confirmed and comorbidities addressed, severe asthma is defined as asthma that requires treatment with high dose inhaled corticosteroids plus a second controller and/or systemic corticosteroids to prevent it from becoming “uncontrolled” or that remains “uncontrolled” despite this therapy. Severe asthma is a heterogeneous condition consisting of phenotypes such as eosinophilic asthma. Specific recommendations on the use of sputum eosinophil count and exhaled nitric oxide to guide therapy, as well as treatment with anti-IgE antibody, methotrexate, macrolide antibiotics, antifungal agents and bronchial thermoplasty are provided. Coordinated research efforts for improved phenotyping will provide safe and effective biomarker-driven approaches to severe asthma therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when “severe asthma” was defined using ERS/ATS (35) or WHO (41) criteria, only a small number of children were classified as having severe asthma, suggesting that we need to look beyond the amount of medication and disease control when defining severe disease (46).”
From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [35]
Citations
Cites
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 2×
“The Committee consisted of clinicians and researchers with recognized expertise in severe asthma (21 pulmonologists of whom 3 were pediatricians, 2 pathologists and 2 physiologists plus one scientist) and an ATS methodologist (JLB) with expertise in the guideline development process and the application of the Grading…”
MethodGLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285 · cited 1×
“confidence in the estimated effects) for each of the outcomes of interest following the GRADE approach [18] based on the following criteria: risk of bias, precision, consistency and magnitude of the estimates of effects, directness of the evidence, risk of publications bias, presence of dose–effect relationship, and a…”
MethodExpert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007) · BMC Medical Research Methodology · doi:10.1186/1471-2288-7-10 · Cited by 4,374
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539 · cited 2×
“While guidelines for the use of biomarkers to guide CS use have been proposed, the use of sputum eosinophils and/or exhaled nitric oxide levels for guiding therapy in severe asthma remains controversial [85] (see GRADE question below).”
(1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.1.225 · Cited by 2,234
Pavord, I. D., Korn, S., Howarth, P., Bleecker, E. R., Buhl, R., Keene, O. N., Ortega, H., & Chanez, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60988-x · Cited by 2,221
Self-citationIdentification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129 · cited 9×
“Chronic airflow limitation which is less responsive to bronchodilators and inhaled or oral CS therapy is observed in some severe asthma phenotypes [9, 11, 26].”
BackgroundMethodInfluentialSelf-citationCluster analysis and clinical asthma phenotypes
Haldar, P., Pavord, I. D., Shaw, D. E., Berry, M. A., Thomas, M., Brightling, C. E., Wardlaw, A. J., & Green, R. H. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1754oc · Cited by 1,987 · cited 10×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundMethodInfluentialSelf-citationReddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918 · cited 2×
“Page 14 of 112 The definition of Severe Asthma was reviewed with reference to the previous definitions [1, 2, 4, 5] and to more recent definitions [6, 7], and in relation to the definition of asthma control and asthma severity of the ATS/ERS Task Force [8].”
MethodSelf-citationGRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911 · cited 1×
“The Committee selected outcomes of interest for each question following the approach suggested by the GRADE Working Group [14].”
MethodMepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Self-citationDisordered Microbial Communities in Asthmatic Airways
Hilty, M., Burke, C., Pedro, H., Cardenas, P., Bush, A., Bossley, C., Davies, J., Ervine, A., Poulter, L., Pachter, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008578 · Cited by 1,824 · cited 1×
“asthma as measured by 16sRNA, but the role of bacteria in severe asthma requires further study [93].”
BackgroundSelf-citationA large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818 · cited 4×
“Early childhood-onset asthma (over a range of severity) is characterized by allergic sensitization, a strong family history and more recently, non-allergy/atopy related genetic factors [13, 27, 32].”
BackgroundInfluentialT-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
Woodruff, P. G., Modrek, B., Choy, D. F., Jia, G., Abbas, A. R., Ellwanger, A., Arron, J. R., Koth, L. L., & Fahy, J. V. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0392oc · Cited by 1,803 · cited 2×
“While the eosinophilic or ‘Th-2 high’ asthma phenotype, characterized by high expression of Th2 cytokines, IL-5 and IL-13, identifies inhaled CS responsiveness in patients with milder asthma, eosinophilic inflammation may persist in some severe asthma patients despite high dose ICS, and even systemic CSs [10, 28, 72,…”
BackgroundAsthma exacerbations and sputum eosinophil counts: a randomised controlled trial
Green, R. H., Brightling, C. E., McKenna, S., Hargadon, B., Parker, D., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11679-5 · Cited by 1,755 · cited 5×
“This review included three randomized controlled trials in adults [182, 249, 250].”
BackgroundMethodInfluentialSelf-citationCan Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., & Pedersen, S. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-033oc · Cited by 1,594 · cited 2×
“composite control scores (such as the Asthma Control Questionnaire or Asthma Control Test ACQ-7/ACT) remain at an uncontrolled level [210, 221, 222].”
BackgroundSelf-citationBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 1×
“Further well designed and rigorously executed randomized trials that measure and properly report [252, 253] patientimportant outcomes are needed, as are studies of patients identified to have an eosinophilic phenotype.”
BackgroundLebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514 · cited 21×
“Page 65 of 112 An antibody to IL-13, lebrikizumab, improved FEV1 in moderately-severe asthmatic adults, without affecting exacerbations and asthma symptoms[70].”
BackgroundResultInfluentialMepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356 · cited 3×
“Eosinophilic inflammation, for instance, is likely to have a Th2 immune component, a reflection of adaptive immunity, as evidenced by four separate studies demonstrating efficacy of a monoclonal antibody to IL-5 in eosinophilic severe asthma in adults [13, 67-69].”
BackgroundWheezing Rhinovirus Illnesses in Early Life Predict Asthma Development in High-Risk Children
Jackson, D. J., Gangnon, R. E., Evans, M. D., Roberg, K. A., Anderson, E. L., Pappas, T. E., Printz, M. C., Lee, W.-M., Shult, P. A., Reisdorf, E., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-309oc · Cited by 1,317 · cited 1×
“relation to asthma severity has rarely been addressed [88-90].”
BackgroundMast-Cell Infiltration of Airway Smooth Muscle in Asthma
Brightling, C. E., Bradding, P., Symon, F. A., Holgate, S. T., Wardlaw, A. J., & Pavord, I. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012705 · Cited by 1,241 · cited 1×
“smooth muscle and epithelial compartments in asthma where they have been linked to poor asthma control and airway hyperresponsiveness [75, 76].”
Self-citationWENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235 · cited 11×
“Tiotropium bromide improved lung function and symptoms in moderate-to-severe asthma patients not controlled on moderate- to high-dose ICSs with or without LABAs [219, 220].”
BackgroundInfluentialSelf-citationWark, P. A. B., Johnston, S. L., Bucchieri, F., Powell, R., Puddicombe, S., Laza-Stanca, V., Holgate, S. T., & Davies, D. E. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041901 · Cited by 1,235 · cited 1×
“Toll-like receptor signalling may also be impaired, leading to inadequate Type I and III interferon (IFN) responses which decrease viral clearance [97].”
BackgroundAsthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Self-citationHumbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J., Beeh, K. ‐., Ramos, S., Canonica, G. W., Hedgecock, S., et al. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00772.x · Cited by 1,123 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodNational Asthma Education and Prevention Program
VanGraafeiland, B. (2002) · The Nurse Practitioner · doi:10.1097/00006205-200206001-00003 · Cited by 1,091
Results of a home-based environmental intervention among urban children with asthma
Morgan, W. J., Crain, E. F., Gruchalla, R. S., O'Connor, G. T., Kattan, M., Evans, R., Stout, J., Malindzak, G., Smartt, E., Plaut, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032097 · Cited by 1,052 · cited 1×
“IgE (as measured by skin prick testing or serum testing), on-going exposures and symptoms may help identify factors which contribute to asthma symptoms and exacerbations [172].”
BackgroundUse of Exhaled Nitric Oxide Measurements to Guide Treatment in Chronic Asthma
Smith, A. D., Cowan, J. O., Brassett, K. P., Herbison, G. P., & Taylor, D. R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043596 · Cited by 974 · cited 1×
“Page 47 of 112 adults [256, 261, 262].”
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
SIMPSON, J. L., SCOTT, R., BOYLE, M. J., & GIBSON, P. G. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00784.x · Cited by 955 · cited 1×
“This inflammation has been categorized into eosinophilic, neutrophilic, and/or paucigranulocytic [13, 28, 56-58].”
BackgroundSelf-citationMoore, W. C., Bleecker, E. R., Curran-Everett, D., Erzurum, S. C., Ameredes, B. T., Bacharier, L., Calhoun, W. J., Castro, M., Chung, K. F., Clark, M. P., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.639 · Cited by 929 · cited 11×
“Tiotropium bromide improved lung function and symptoms in moderate-to-severe asthma patients not controlled on moderate- to high-dose ICSs with or without LABAs [219, 220].”
BackgroundInfluentialSelf-citation(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.ats9-00 · Cited by 909
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
Busse, W. W., Morgan, W. J., Gergen, P. J., Mitchell, H. E., Gern, J. E., Liu, A. H., Gruchalla, R. S., Kattan, M., Teach, S. J., Pongracic, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009705 · Cited by 884
Neutrophilic Inflammation in Severe Persistent Asthma
JATAKANON, A., UASUF, C., MAZIAK, W., LIM, S., CHUNG, K. F., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9806170 · Cited by 851 · cited 7×
“Tiotropium bromide improved lung function and symptoms in moderate-to-severe asthma patients not controlled on moderate- to high-dose ICSs with or without LABAs [219, 220].”
BackgroundInfluentialSelf-citationRecommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
(MCAAS), M. C. C. A. S., Ober, C., study, C. H. S. (. A. H., Genetics of Asthma in Latino Americans (GALA) Study, T. S. O. G.-E. A. A. I. L. A. (. A. T. S. O. A. A., Childhood Asthma Research and Education (CARE) Network, (CAMP), C. A. M. P., (SAPPHIRE), S. O. A. P. A. P. I. B. R.-E., Study, G. R. O. A. I. T. A. D. (., & Nicolae, D. L. (2011) · Nature Genetics · doi:10.1038/ng.888 · Cited by 833
Solèr, M., Matz, J., Townley, R., Buhl, R., O'Brien, J., Fox, H., Thirlwell, J., Gupta, N., & Della Cioppa, G. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.00092101 · Cited by 827
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826 · cited 1×
“recent genomic and proteomic approaches have suggested increases in IL-1β in certain asthmatics, in conjunction with neutrophilia [107-109].”
BackgroundSelf-citationTH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice
McKinley, L., Alcorn, J. F., Peterson, A., DuPont, R. B., Kapadia, S., Logar, A., Henry, A., Irvin, C. G., Piganelli, J. D., Ray, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4089 · Cited by 777
The ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750 · cited 1×
“While the anti-IL5 antibody, mepolizumab, was not beneficial in unselected adult patients with moderate asthma [321], when studied in severe asthma patients with persistent sputum”
BackgroundSelf-citationBousquet, J., Mantzouranis, E., Cruz, A. A., Aït-Khaled, N., Baena-Cagnani, C. E., Bleecker, E. R., Brightling, C. E., Burney, P., Bush, A., Busse, W. W., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.019 · Cited by 741 · cited 4×
“Page 18 of 112 including CSs, and asthma complicated by comorbidities, the types of greatest concern to the countries primarily served by the two societies [6].”
BackgroundMethodResultInfluentialSelf-citationReslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study
Castro, M., Mathur, S., Hargreave, F., Boulet, L.-P., Xie, F., Young, J., Wilkins, H. J., Henkel, T., & Nair, P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0396oc · Cited by 716
Self-citationFahy, J. V., Fleming, H. E., Wong, H. H., Liu, J. T., Su, J. Q., Reimann, J., Fick, R. B., & Boushey, H. A. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196082 · Cited by 713 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodGrossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody
Milgrom, H., Fick, R. B., Su, J. Q., Reimann, J. D., Bush, R. K., Watrous, M. L., & Metzger, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412603 · Cited by 704
Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
Kerstjens, H. A. M., Engel, M., Dahl, R., Paggiaro, P., Beck, E., Vandewalker, M., Sigmund, R., Seibold, W., Moroni-Zentgraf, P., & Bateman, E. D. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1208606 · Cited by 669 · cited 1×
“In patients taking high doses of ICSs and LABAs, the addition of tiotropium bromide provided improvements in FEV1, reduced as-needed use of short-acting β2-adrenergic agonists and modestly reduced the risk of a severe exacerbation [244, 246].”
BackgroundSelf-citationDjukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 646
Self-citationTH17-associated cytokines (IL-17A and IL-17F) in severe asthma
Al-Ramli, W., Préfontaine, D., Chouiali, F., Martin, J. G., Olivenstein, R., Lemière, C., & Hamid, Q. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.024 · Cited by 637
Self-citationPeriostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615 · cited 16×
“In a post-hoc analysis, this antibody improved prebronchodilator FEV1 in the group with evidence for Th2 inflammation as measured by elevated serum TABLE 9 Potential phenotype-targeted therapies in severe asthma# Characteristic Associations Specifically targeted treatments Severe allergic asthma Blood and sputum eosin…”
BackgroundInfluentialSelf-citationDetermining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Jayaram, L., Pizzichini, M. M., Cook, R. J., Boulet, L.-P., Lemière, C., Pizzichini, E., Cartier, A., Hussack, P., Goldsmith, C. H., Laviolette, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00137704 · Cited by 603
Self-citationDistinguishing severe asthma phenotypes
Miranda, C., Busacker, A., Balzar, S., Trudeau, J., & Wenzel, S. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.041 · Cited by 586 · cited 5×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundInfluentialSelf-citationFriedman, M. S. (2001) · JAMA · doi:10.1001/jama.285.7.897 · Cited by 584 · cited 1×
“environmental ozone levels following reduction in traffic congestion was associated with improvement in asthma outcomes in an urban environment [177].”
BackgroundSelf-citationXystrakis, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci21759 · Cited by 582
Asthma Control during the Year after Bronchial Thermoplasty
Cox, G., Thomson, N. C., Rubin, A. S., Niven, R. M., Corris, P. A., Siersted, H. C., Olivenstein, R., Pavord, I. D., McCormack, D., Chaudhuri, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064707 · Cited by 576 · cited 3×
“All included the same 3 randomized trials: a study in patients with asthma of variable severity [20], and 2 studies specifically including patients with severe asthma – one comparing thermoplasty with usual care [315] and one with a sham procedure [313].”
BackgroundThe Relationship between Airways Inflammation and Asthma Severity
LOUIS, R., LAU, L. C. K., BRON, A. O., ROLDAAN, A. C., RADERMECKER, M., & DJUKANOVIĆ, R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9802048 · Cited by 571 · cited 1×
“However, both eosinophil and neutrophil sputum numbers show wide variability in severe asthma with patients demonstrating none to very high levels of either cell, despite being on high doses of CS [59-61].”
BackgroundHanania, N. A., Alpan, O., Hamilos, D. L., Condemi, J. J., Reyes-Rivera, I., Zhu, J., Rosen, K. E., Eisner, M. D., Wong, D. A., & Busse, W. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00002 · Cited by 554 · cited 3×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
BackgroundMethodInfluence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
Chalmers, G. W. (2002) · Thorax · doi:10.1136/thorax.57.3.226 · Cited by 545 · cited 1×
“CS insensitivity has been associated with different co-morbid conditions such as obesity [195], smoking [196], low vitamin D levels [197, 198], and non-eosinophilic (low-Th2 inflammation) mainly in adults [199].”
BackgroundBeuther, D. A., Weiss, S. T., & Sutherland, E. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-231pp · Cited by 541
Non-eosinophilic cor ticosteroid unresponsive asthma
Pavord, I. D., Brightling, C. E., Woltmann, G., & Wardlaw, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01813-9 · Cited by 528 · cited 1×
“phenotypes which may be helpful when considering nonspecific (CS) and specific (targeted) therapy (eg, anti-IgE, anti-IL5 and anti-IL13 antibody treatments) [13, 38, 55, 69, 70, 182-186]”
Self-citationTreatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)
Milgrom, H., Berger, W., Nayak, A., Gupta, N., Pollard, S., McAlary, M., Taylor, A. F., & Rohane, P. (2001) · Pediatrics · doi:10.1542/peds.108.2.e36 · Cited by 525 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodHolgate, S. T., Chuchalin, A. G., Hébert, J., Lötvall, J., Persson, G. B., Chung, K. F., Bousquet, J., Kerstjens, H. A., Fox, H., Thirlwell, J., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1916.x · Cited by 522
Self-citationTiotropium Bromide Step-Up Therapy for Adults with Uncontrolled Asthma
Peters, S. P., Kunselman, S. J., Icitovic, N., Moore, W. C., Pascual, R., Ameredes, B. T., Boushey, H. A., Calhoun, W. J., Castro, M., Cherniack, R. M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008770 · Cited by 519
Self-citationEarly Thickening of the Reticular Basement Membrane in Children with Difficult Asthma
Payne, D. N. R., Rogers, A. V., Ädelroth, E., Bandi, V., Guntupalli, K. K., Bush, A., & Jeffery, P. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-414oc · Cited by 512 · cited 1×
“Subepithelial thickening of the bronchial reticular layer is an early feature of severe asthma in children, and appears to be a characteristic of the eosinophilic phenotype [28, 123, 124].”
BackgroundSelf-citationKips, J. C., O'Connor, B. J., Langley, S. J., Woodcock, A., Kerstjens, H. A. M., Postma, D. S., Danzig, M., Cuss, F., & Pauwels, R. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-525oc · Cited by 494 · cited 1×
“Kips et al, 2003 [327] Severe/26 R, db, pc, p SCH55700, antiIL-5, 12 w Sputum and blood eos, symptoms, FEV1 Reduced blood sputum eos No other significant outcomes Castro et al 2011, [68] Poorlycontrolled on high-dose inhaled CS/53 R, db, pc, p Reslimuzab, antiIL-5, 12 w ACQ FEV1 Sputum eos Improved ACQ score Reduction…”
BackgroundRisk factors of frequent exacerbations in difficult-to-treat asthma
ten Brinke, A., Sterk, P. J., Masclee, A. A. M., Spinhoven, P., Schmidt, J. T., Zwinderman, A. H., Rabe, K. F., & Bel, E. H. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00037905 · Cited by 490
Self-citationBerry, M., Morgan, A., Shaw, D. E., Parker, D., Green, R., Brightling, C., Bradding, P., Wardlaw, A. J., & Pavord, I. D. (2007) · Thorax · doi:10.1136/thx.2006.073429 · Cited by 483 · cited 1×
“CS insensitivity has been associated with different co-morbid conditions such as obesity [195], smoking [196], low vitamin D levels [197, 198], and non-eosinophilic (low-Th2 inflammation) mainly in adults [199].”
BackgroundSelf-citationFungi and allergic lower respiratory tract diseases
Knutsen, A. P., Bush, R. K., Demain, J. G., Denning, D. W., Dixit, A., Fairs, A., Greenberger, P. A., Kariuki, B., Kita, H., Kurup, V. P., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.970 · Cited by 482 · cited 1×
“Sensitization to fungi such as aspergillus has also been associated with severe asthma development in adults [44, 45]”
BackgroundClarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J., & Gibson, P. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1134oc · Cited by 482 · cited 5×
“Two studies included children [300, 306] and two included adults [301, 305].”
BackgroundInfluentialSelf-citationKitler, M. E. (2005) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200519040-00007 · Cited by 480
Influence of body mass index on the response to asthma controller agents
Peters-Golden, M., Swern, A., Bird, S. S., Hustad, C. M., Grant, E., & Edelman, J. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00077205 · Cited by 479
A Large Subgroup of Mild-to-Moderate Asthma Is Persistently Noneosinophilic
McGrath, K. W., Icitovic, N., Boushey, H. A., Lazarus, S. C., Sutherland, E. R., Chinchilli, V. M., & Fahy, J. V. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1640oc · Cited by 478 · cited 2×
“While the eosinophilic or ‘Th-2 high’ asthma phenotype, characterized by high expression of Th2 cytokines, IL-5 and IL-13, identifies inhaled CS responsiveness in patients with milder asthma, eosinophilic inflammation may persist in some severe asthma patients despite high dose ICS, and even systemic CSs [10, 28, 72,…”
BackgroundHastie, A. T., Moore, W. C., Meyers, D. A., Vestal, P. L., Li, H., Peters, S. P., & Bleecker, E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.008 · Cited by 463
Self-citationWenzel, S. E., Barnes, P. J., Bleecker, E. R., Bousquet, J., Busse, W., Dahlén, S.-E., Holgate, S. T., Meyers, D. A., Rabe, K. F., Antczak, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1512oc · Cited by 460 · cited 3×
“Similarly, an anti-TNFα antibody, golimumab, was also ineffective in a study performed in adults with uncontrolled severe persistent asthmatic adults [110], but post-hoc analysis suggested an effect in a subgroup.”
BackgroundResultInfluentialSelf-citationSzefler, S. J., Mitchell, H., Sorkness, C. A., Gergen, P. J., O'Connor, G. T., Morgan, W. J., Kattan, M., Pongracic, J. A., Teach, S. J., Bloomberg, G. R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61448-8 · Cited by 458 · cited 1×
“Four studies explicitly included children [47, 257-259], one included adolescents [260], and three studies enrolled”
BackgroundFitzpatrick, A. M., Teague, W. G., Meyers, D. A., Peters, S. P., Li, X., Li, H., Wenzel, S. E., Aujla, S., Castro, M., Bacharier, L. B., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.015 · Cited by 446 · cited 4×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundInfluentialSelf-citationSmoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in Asthma
Lazarus, S. C., Chinchilli, V. M., Rollings, N. J., Boushey, H. A., Cherniack, R., Craig, T. J., Deykin, A., DiMango, E., Fish, J. E., Ford, J. G., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1746oc · Cited by 445 · cited 1×
“Smoking appears to alter the inflammatory process which may contribute to their reported lower responses to CS therapy [39, 42].”
BackgroundObesity and asthma: An association modified by age of asthma onset
Holguin, F., Bleecker, E. R., Busse, W. W., Calhoun, W. J., Castro, M., Erzurum, S. C., Fitzpatrick, A. M., Gaston, B., Israel, E., Jarjour, N. N., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.036 · Cited by 443
Self-citationStep-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Lemanske, R. F., Mauger, D. T., Sorkness, C. A., Jackson, D. J., Boehmer, S. J., Martinez, F. D., Strunk, R. C., Szefler, S. J., Zeiger, R. S., Bacharier, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001278 · Cited by 441
Mattes, J., Collison, A., Plank, M., Phipps, S., & Foster, P. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905063106 · Cited by 430 · cited 3×
“A role for miRNAs in regulating Th2 function, subsequent allergic airways disease and T-cell production of IL-13 has been proposed from murine studies [53, 54].”
BackgroundResultA cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.
Suissa, S., Ernst, P., Boivin, J. F., Horwitz, R. I., Habbick, B., Cockroft, D., Blais, L., McNutt, M., Buist, A. S., & Spitzer, W. O. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.3.8118625 · Cited by 422
Stern, D. A., Morgan, W. J., Halonen, M., Wright, A. L., & Martinez, F. D. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61447-6 · Cited by 418 · cited 1×
“clear [35].”
Dixon, A. E., Pratley, R. E., Forgione, P. M., Kaminsky, D. A., Whittaker-Leclair, L. A., Griffes, L. A., Garudathri, J., Raymond, D., Poynter, M. E., Bunn, J. Y., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.06.009 · Cited by 413 · cited 4×
“Similarly, an adult-onset obese asthma phenotype may respond better to weight loss strategies than an obese, early onset allergic asthmatic patient[38].”
BackgroundInfluentialSafety and Efficacy of Bronchial Thermoplasty in Symptomatic, Severe Asthma
Pavord, I. D., Cox, G., Thomson, N. C., Rubin, A. S., Corris, P. A., Niven, R. M., Chung, K. F., Laviolette, M., & the RISA Trial Study Group (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200704-571oc · Cited by 410 · cited 1×
“All included the same 3 randomized trials: a study in patients with asthma of variable severity [20], and 2 studies specifically including patients with severe asthma – one comparing thermoplasty with usual care [315] and one with a sham procedure [313].”
BackgroundSelf-citationVignola, A. M., Humbert, M., Bousquet, J., Boulet, L., Hedgecock, S., Blogg, M., Fox, H., & Surrey, K. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00550.x · Cited by 405 · cited 3×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
BackgroundMethodSelf-citationOverdiagnosis of asthma in obese and nonobese adults
Aaron, S. D., Vandemheen, K. L., Boulet, L.-P., McIvor, R. A., FitzGerald, J. M., Hernandez, P., Lemiere, C., Sharma, S., Field, S. K., Alvarez, G. G., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.081332 · Cited by 400 · cited 1×
“conditions as uncontrolled asthma has been reported to be as high as 12-30% [141, 142].”
BackgroundSelf-citationUpdate on glucocorticoid action and resistance
Ito, K., Chung, K. F., & Adcock, I. M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.032 · Cited by 397 · cited 1×
“Understanding the mechanisms underlying these different types of CS insensitivity could lead to novel treatments such as p38 mitogen-activated protein kinase (MAPK) inhibitors and histone deacetylase-2 (HDAC-2) recruiters [202, 203].”
BackgroundSelf-citationDAHLÉN, B., NIZANKOWSKA, E., SZCZEKLIK, A., ZETTERSTRÖM, O., BOCHENEK, G., KUMLIN, M., MASTALERZ, L., PINIS, G., SWANSON, L. J., BOODHOO, T. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707089 · Cited by 396
Expression of the T Helper 17-Associated Cytokines IL-17A and IL-17F in Asthma and COPD
Doe, C., Bafadhel, M., Siddiqui, S., Desai, D., Mistry, V., Rugman, P., McCormick, M., Woods, J., May, R., Sleeman, M. A., et al. (2010) · Chest · doi:10.1378/chest.09-3058 · Cited by 394 · cited 1×
“In contrast, other elements of innate immunity may be enhanced, including increased expression of TSLP, IL-25, and IL-33 in airway cells from patients with severe asthma [81, 100, 101].”
BackgroundSelf-citationTotal Eosinophil Counts in the Management of Bronchial Asthma
Horn, B. R., Robin, E. D., Theodore, J., & Van Kessel, A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505292922204 · Cited by 393 · cited 1×
“phenotypes which may be helpful when considering nonspecific (CS) and specific (targeted) therapy (eg, anti-IgE, anti-IL5 and anti-IL13 antibody treatments) [13, 38, 55, 69, 70, 182-186]”
BackgroundVIGNOLA, A. M., RICCOBONO, L., MIRABELLA, A., PROFITA, M., CHANEZ, P., BELLIA, V., MAUTINO, G., D'ACCARDI, P., BOUSQUET, J., & BONSIGNORE, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9803014 · Cited by 389 · cited 1×
“Finally, severe airway obstruction is a characteristic in some phenotypes of severe asthma, with studies suggesting that eosinophilic and/or neutrophilic inflammation may contribute to greater airflow limitation [127, 133, 134].”
BackgroundSelf-citationEfficacy of Esomeprazole for Treatment of Poorly Controlled Asthma
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806290 · Cited by 382
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Piper, E., Brightling, C., Niven, R., Oh, C., Faggioni, R., Poon, K., She, D., Kell, C., May, R. D., Geba, G. P., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00223411 · Cited by 373
Self-citationEffect of Inhaled Glucocorticoids in Childhood on Adult Height
Kelly, H. W., Sternberg, A. L., Lescher, R., Fuhlbrigge, A. L., Williams, P., Zeiger, R. S., Raissy, H. H., Van Natta, M. L., Tonascia, J., & Strunk, R. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203229 · Cited by 371 · cited 1×
“accompanied by a persistent reduction in adult height, although the decrease was neither progressive nor cumulative [219].”
BackgroundGenomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma
Tantisira, K. G., Lasky-Su, J., Harada, M., Murphy, A., Litonjua, A. A., Himes, B. E., Lange, C., Lazarus, R., Sylvia, J., Klanderman, B., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0911353 · Cited by 366 · cited 1×
“inhaled corticosteroids or even specific novel biologic therapies could exhibit more difficult-tocontrol asthma and be classified as more severe [51, 52].”
BackgroundLanier, B., Bridges, T., Kulus, M., Taylor, A. F., Berhane, I., & Vidaurre, C. F. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.021 · Cited by 360 · cited 3×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
BackgroundMethodFactors Associated with Persistent Airflow Limitation in Severe Asthma
ten BRINKE, A., ZWINDERMAN, A. H., STERK, P. J., RABE, K. F., & BEL, E. H. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2011026 · Cited by 360
Self-citationErs Task Force on Difficult/therapy-Resistant Asthma, & Members of the Task Force: K.F. Chung and P. Godard (co-chairmen), E. A. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.13e43.x · Cited by 351
Self-citationEvans, D. J., Taylor, D. A., Zetterstrom, O., Chung, K. F., O'Connor, B. J., & Barnes, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372002 · Cited by 348
Self-citationBody Mass and Glucocorticoid Response in Asthma
Sutherland, E. R., Goleva, E., Strand, M., Beuther, D. A., & Leung, D. Y. M. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-076oc · Cited by 347 · cited 1×
“CS insensitivity has been associated with different co-morbid conditions such as obesity [195], smoking [196], low vitamin D levels [197, 198], and non-eosinophilic (low-Th2 inflammation) mainly in adults [199].”
BackgroundTitrating Steroids on Exhaled Nitric Oxide in Children with Asthma: A Randomized Controlled Trial
Pijnenburg, M. W., Bakker, E. M., Hop, W. C., & De Jongste, J. C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-458oc · Cited by 346 · cited 1×
“Four studies explicitly included children [47, 257-259], one included adolescents [260], and three studies enrolled”
BackgroundBel, E. H., Sousa, A., Fleming, L., Bush, A., Chung, K. F., Versnel, J., Wagener, A. H., Wagers, S. S., Sterk, P. J., Compton, C. H., et al. (2011) · Thorax · doi:10.1136/thx.2010.153643 · Cited by 343 · cited 2×
“Page 14 of 112 The definition of Severe Asthma was reviewed with reference to the previous definitions [1, 2, 4, 5] and to more recent definitions [6, 7], and in relation to the definition of asthma control and asthma severity of the ATS/ERS Task Force [8].”
MethodResultSelf-citationDenning, D. W., O'Driscoll, B. R., Powell, G., Chew, F., Atherton, G. T., Vyas, A., Miles, J., Morris, J., & Niven, R. M. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-737oc · Cited by 343
The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial
Shaw, D. E., Berry, M. A., Thomas, M., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1427oc · Cited by 341 · cited 1×
“Page 47 of 112 adults [256, 261, 262].”
Self-citationPowell, H., Murphy, V. E., Taylor, D. R., Hensley, M. J., McCaffery, K., Giles, W., Clifton, V. L., & Gibson, P. G. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60971-9 · Cited by 339
Self-citationPetsky, H. L., Cates, C. J., Lasserson, T. J., Li, A. M., Turner, C., Kynaston, J. A., & Chang, A. B. (2012) · Thorax · doi:10.1136/thx.2010.135574 · Cited by 338 · cited 2×
“We found one systematic review addressing that question, the results of which have been published in two documents [247, 255].”
BackgroundNair, P., Gaga, M., Zervas, E., Alagha, K., Hargreave, F. E., O'Byrne, P. M., Stryszak, P., Gann, L., Sadeh, J., Chanez, P., et al. (2012) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2012.04014.x · Cited by 333 · cited 2×
“Nair et al, 2012 [326] Severe asthma/34 R, db, pc, p SCH527123, CXCR2 receptor antagonist, 4 weeks Changes in sputum and neutrophil activation markers Reduction in blood and sputum neutrophil.”
BackgroundSelf-citationIncreased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Shikotra, A., Choy, D. F., Ohri, C. M., Doran, E., Butler, C., Hargadon, B., Shelley, M., Abbas, A. R., Austin, C. D., Jackman, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.031 · Cited by 333 · cited 1×
“In contrast, other elements of innate immunity may be enhanced, including increased expression of TSLP, IL-25, and IL-33 in airway cells from patients with severe asthma [81, 100, 101].”
BackgroundDAHLÉN, S.-E., MALMSTRÖM, K., NIZANKOWSKA, E., DAHLÉN, B., KUNA, P., KOWALSKI, M., LUMRY, W. R., PICADO, C., STEVENSON, D. D., BOUSQUET, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.1.2010080 · Cited by 330
Lajoie, S., Lewkowich, I. P., Suzuki, Y., Clark, J. R., Sproles, A. A., Dienger, K., Budelsky, A. L., & Wills-Karp, M. (2010) · Nature Immunology · doi:10.1038/ni.1926 · Cited by 329 · cited 1×
“been implicated as a cause for neutrophilia, primarily in murine models of asthma, with some supporting data from severe asthma [77, 79-81].”
ResultGupta, A., Sjoukes, A., Richards, D., Banya, W., Hawrylowicz, C., Bush, A., & Saglani, S. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201107-1239oc · Cited by 326 · cited 1×
“CS insensitivity has been associated with different co-morbid conditions such as obesity [195], smoking [196], low vitamin D levels [197, 198], and non-eosinophilic (low-Th2 inflammation) mainly in adults [199].”
BackgroundSelf-citationSorkness, R. L., Bleecker, E. R., Busse, W. W., Calhoun, W. J., Castro, M., Chung, K. F., Curran-Everett, D., Erzurum, S. C., Gaston, B. M., Israel, E., et al. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00329.2007 · Cited by 322 · cited 1×
“Severe asthmatics were found to exhibit air trapping (reduced FVC in relation to FEV1/FVC) when compared with non-severe asthmatics at matched levels of airflow limitation measured by FEV1/FVC ratio [132].”
ResultSelf-citationEffects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma
Chaudhuri, R., Livingston, E., McMahon, A. D., Lafferty, J., Fraser, I., Spears, M., McSharry, C. P., & Thomson, N. C. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1589oc · Cited by 321 · cited 2×
“and environmental air pollution are routinely linked as risk factors for more severe asthma [39, 40].”
BackgroundGenome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions
Li, X., Howard, T. D., Zheng, S. L., Haselkorn, T., Peters, S. P., Meyers, D. A., & Bleecker, E. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.11.018 · Cited by 318 · cited 1×
“There is increasing evidence that severe asthma phenotypes are related to genetic factors, age of asthma onset, disease duration, exacerbations, sinus disease and inflammatory characteristics [13, 26, 27, 29-31].”
BackgroundSelf-citationPediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines
Bossley, C. J., Fleming, L., Gupta, A., Regamey, N., Frith, J., Oates, T., Tsartsali, L., Lloyd, C. M., Bush, A., & Saglani, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.059 · Cited by 316 · cited 8×
“Tiotropium bromide improved lung function and symptoms in moderate-to-severe asthma patients not controlled on moderate- to high-dose ICSs with or without LABAs [219, 220].”
BackgroundResultInfluentialSelf-citationChronic sinusitis in severe asthma is related to sputum eosinophilia
ten Brinke, A., Grootendorst, D. C., Schmidt, J. T., de Bruïne, F. T., van Buchem, M. A., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.122458 · Cited by 311
Self-citationAysola, R. S., Hoffman, E. A., Gierada, D., Wenzel, S., Cook-Granroth, J., Tarsi, J., Zheng, J., Schechtman, K. B., Ramkumar, T. P., Cochran, R., et al. (2008) · Chest · doi:10.1378/chest.07-2779 · Cited by 303 · cited 3×
“Finally, severe airway obstruction is a characteristic in some phenotypes of severe asthma, with studies suggesting that eosinophilic and/or neutrophilic inflammation may contribute to greater airflow limitation [127, 133, 134].”
BackgroundSelf-citationA meta-analysis of the effect of oral and inhaled corticosteroids on growth
Allen, D. B., Mullen, M., & Mullen, B. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(94)70043-5 · Cited by 300 · cited 1×
“while high doses of ICS are associated with an increased risk of adrenal suppression and growth retardation in children [213, 215-217].”
BackgroundA Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Corren, J., Busse, W., Meltzer, E. O., Mansfield, L., Bensch, G., Fahrenholz, J., Wenzel, S. E., Chon, Y., Dunn, M., Weng, H. H., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1448oc · Cited by 299
Self-citationTranscriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples
Baines, K. J., Simpson, J. L., Wood, L. G., Scott, R. J., & Gibson, P. G. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.024 · Cited by 298 · cited 1×
“recent genomic and proteomic approaches have suggested increases in IL-1β in certain asthmatics, in conjunction with neutrophilia [107-109].”
BackgroundSelf-citationCox, L., Platts-Mills, T. A. E., Finegold, I., Schwartz, L. B., Simons, F. E. R., & Wallace, D. V. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.032 · Cited by 295
Balzar, S., Fajt, M. L., Comhair, S. A. A., Erzurum, S. C., Bleecker, E., Busse, W. W., Castro, M., Gaston, B., Israel, E., Schwartz, L. B., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0295oc · Cited by 293
Self-citationSystematic assessment of difficult-to-treat asthma
Robinson, D. S., Campbell, D. A., Durham, S. R., Pfeffer, J., Barnes, P. J., & Chung, K. F. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00017003 · Cited by 289 · cited 3×
“conditions as uncontrolled asthma has been reported to be as high as 12-30% [141, 142].”
BackgroundSelf-citationBusacker, A., Newell, J. D., Keefe, T., Hoffman, E. A., Granroth, J. C., Castro, M., Fain, S., & Wenzel, S. (2009) · Chest · doi:10.1378/chest.08-0049 · Cited by 287 · cited 2×
“morphometry of the airways and distal lung in adults with severe asthma, but with less is known in children [126-129].”
BackgroundSelf-citationVans, D. A. J. E., Aylor, D. A. A. T., Etterstrom, O. L. Z., Hung, K. F. A. C., & Arnes, P. E. J. B. (1997) · Cited by 284
Evaluation of Asthma With Hyperpolarized Helium-3 MRI
de Lange, E. E., Altes, T. A., Patrie, J. T., Gaare, J. D., Knake, J. J., Mugler, J. P., & Platts-Mills, T. A. (2006) · Chest · doi:10.1378/chest.130.4.1055 · Cited by 279
Bronchial Thermoplasty for Asthma
Cox, G., Miller, J. D., McWilliams, A., FitzGerald, J. M., & Lam, S. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200507-1162oc · Cited by 278 · cited 1×
“We identified additional 2 reports of the follow-up of patients from 2 included RCTs [316, 317], and 2 case series [318, 319] but we used only the evidence from RCTs to inform this recommendation.”
MethodKerstjens, H. A. M., Disse, B., Schröder-Babo, W., Bantje, T. A., Gahlemann, M., Sigmund, R., Engel, M., & van Noord, J. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.039 · Cited by 276 · cited 13×
“Page 43 of 112 Tiotropium bromide improved lung function and symptoms in moderate-to-severe asthma patients not controlled on moderate- to high-dose ICSs with or without LABAs [244, 245].”
BackgroundInfluentialRelative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe Asthma
Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P. J., Adcock, I., & Fan Chung, K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1930oc · Cited by 271 · cited 1×
“It can be demonstrated in peripheral blood mononuclear cells and alveolar macrophages, and in resident cells such as airway smooth muscle cells from patients with severe asthma [191-194], but the relation of these in vitro studies to in vivo responses is not well understood.”
BackgroundSelf-citationLynch, D. A., Newell, J. D., Tschomper, B. A., Cink, T. M., Newman, L. S., & Bethel, R. (1993) · Radiology · doi:10.1148/radiology.188.3.8351357 · Cited by 270 · cited 1×
“selection criteria were reported in the article or not) [126, 156-159].”
BackgroundDweik, R. A., Sorkness, R. L., Wenzel, S., Hammel, J., Curran-Everett, D., Comhair, S. A. A., Bleecker, E., Busse, W., Calhoun, W. J., Castro, M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200905-0695oc · Cited by 270 · cited 22×
“Daclizumab, a humanised IgG1 monoclonal antibody against the IL-2 receptor-a chain of activated lymphocytes improved FEV1 and asthma control in moderate-to-severe asthmatic adults inadequately controlled on ICS [162].”
BackgroundInfluentialSelf-citationRodrigo, G. J., Neffen, H., & Castro-Rodriguez, J. A. (2011) · Chest · doi:10.1378/chest.10-1194 · Cited by 268 · cited 1×
“We found 3 systematic reviews [265-267] published in 2006 and 2011 that addressed that question.”
BackgroundAccumulation of intraepithelial mast cells with a unique protease phenotype in TH2-high asthma
Dougherty, R. H., Sidhu, S. S., Raman, K., Solon, M., Solberg, O. D., Caughey, G. H., Woodruff, P. G., & Fahy, J. V. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.03.003 · Cited by 254
Diminished Lipoxin Biosynthesis in Severe Asthma
Levy, B. D., Bonnans, C., Silverman, E. S., Palmer, L. J., Marigowda, G., & Israel, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1413oc · Cited by 250
Bhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P. J., Adcock, I., & Chung, K. F. (2008) · Thorax · doi:10.1136/thx.2007.090027 · Cited by 246 · cited 1×
“It can be demonstrated in peripheral blood mononuclear cells and alveolar macrophages, and in resident cells such as airway smooth muscle cells from patients with severe asthma [191-194], but the relation of these in vitro studies to in vivo responses is not well understood.”
BackgroundSelf-citationComputed tomography of the lungs in asthma: influence of disease severity and etiology.
Paganin, F., Séneterre, E., Chanez, P., Daurés, J. P., Bruel, J. M., Michel, F. B., & Bousquet, J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.1.8542102 · Cited by 246 · cited 2×
“Similarly, Paganin and colleagues reported two studies that investigated 13 and 37 patients with possible severe asthma (Aas score 4 or 5) and no particular selection criteria; the sampled population was also not described [161, 162].”
BackgroundSelf-citationLansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial
Writing Committee for the American Lung Association Asthma Clinical Research Centers, Holbrook, J. T., Wise, R. A., Gold, B. D., Blake, K., Brown, E. D., Castro, M., Dozor, A. J., Lima, J. J., Mastronarde, J. G., et al. (2012) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.2011.2035 · Cited by 244
Self-citationAbnormal Alveolar Attachments with Decreased Elastic Fiber Content in Distal Lung in Fatal Asthma
Mauad, T., Silva, L. F. F., Santos, M. A., Grinberg, L., Bernardi, F. D. C., Martins, M. A., Saldiva, P. H. N., & Dolhnikoff, M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-305oc · Cited by 243 · cited 1×
“attachments in asthma deaths remains to be confirmed [138].”
BackgroundSelf-citationParameters associated with persistent airflow obstruction in chronic severe asthma
Bumbacea, D., Campbell, D., Nguyen, L., Carr, D., Barnes, P. J., Robinson, D., & Chung, K. F. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00077803 · Cited by 243 · cited 5×
“Many adult and paediatric patients with severe asthma have persistent chronic airflow obstruction despite treatment with ICS and short and/or long-acting bronchodilators [33, 134].”
BackgroundResultInfluentialSelf-citationEpithelial Cell Proliferation Contributes to Airway Remodeling in Severe Asthma
Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T. K., Cochran, R., DeMartino, S., Schechtman, K. B., Hussain, I., Holtzman, M. J., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-1062oc · Cited by 239 · cited 1×
“First, the epithelium in severe asthma is reported to be thicker than in mild-moderate asthma [115], with altered proliferation, apoptosis and release of pro-inflammatory factors [116].”
BackgroundSelf-citationRodrigo, G. J., & Castro-Rodriguez, J. A. (2005) · Thorax · doi:10.1136/thx.2005.047803 · Cited by 238 · cited 1×
“as in the treatment of asthma exacerbations [233, 234].”
BackgroundAnti-IgE for chronic asthma in adults and children
Walker, S., Monteil, M., Phelan, K., Lasserson, T. J., & Walters, E. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003559.pub3 · Cited by 236
VEEN, J. C. C. M. I., BEEKMAN, A. J., BEL, E. H., & STERK, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9906075 · Cited by 235
Self-citationChildren and the Risk of Fractures Caused by Oral Corticosteroids
van Staa, T., Cooper, C., Leufkens, H., & Bishop, N. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.913 · Cited by 233
Allen, D. B., Bielory, L., Derendorf, H., Dluhy, R., Colice, G. L., & Szefler, S. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01859-1 · Cited by 231 · cited 2×
“while high doses of ICS are associated with an increased risk of adrenal suppression and growth retardation in children [213, 215-217].”
BackgroundHeterogeneity of Bronchial Asthma: Sub‐populations – or Different Stages of the Disease
Aas, K. (1981) · Allergy · doi:10.1111/j.1398-9995.1981.tb01818.x · Cited by 228 · cited 1×
“However, it is most likely that fewer than 20% of these patients might have had severe asthma (Aas score 4 or 5 [165] defined as >5 episodes totalling ≥6 months per year with prolonged obstruction following most episodes, chronic symptomatic obstruction with restriction of function, or chronic, incapacitating asthma w…”
BackgroundCollison, A., Mattes, J., Plank, M., & Foster, P. S. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.005 · Cited by 225 · cited 1×
“A role for miRNAs in regulating Th2 function, subsequent allergic airways disease and T-cell production of IL-13 has been proposed from murine studies [53, 54].”
Background(2010) · Thorax · doi:10.1136/thx.2005.040444 · Cited by 224
Brutsche, M. H., Brutsche, I. C., Munawar, M., Langley, S. J., Masterson, C. M., Daley-Yates, P. T., Brown, R., Custovic, A., & Woodcock, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02581-2 · Cited by 221 · cited 2×
“composite control scores (such as the Asthma Control Questionnaire or Asthma Control Test ACQ-7/ACT) remain at an uncontrolled level [210, 221, 222].”
BackgroundRisk of severe asthma episodes predicted from fluctuation analysis of airway function
Frey, U., Brodbeck, T., Majumdar, A., Robin Taylor, D., Ian Town, G., Silverman, M., & Suki, B. (2005) · Nature · doi:10.1038/nature04176 · Cited by 220 · cited 1×
“lung function over days [135, 139].”
Self-citationManagement of severe asthma in children
Bush, A., & Saglani, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61054-9 · Cited by 220
Self-citationQualitative Analysis of High-Resolution CT Scans in Severe Asthma
Gupta, S., Siddiqui, S., Haldar, P., Raj, J. V., Entwisle, J. J., Wardlaw, A. J., Bradding, P., Pavord, I. D., Green, R. H., & Brightling, C. E. (2009) · Chest · doi:10.1378/chest.09-0174 · Cited by 219 · cited 2×
“morphometry of the airways and distal lung in adults with severe asthma, but with less is known in children [126-129].”
BackgroundSelf-citationDaily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma
de Jongste, J. C., Carraro, S., Hop, W. C., the CHARISM Study Group, & Baraldi, E. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1010oc · Cited by 216 · cited 1×
“Four studies explicitly included children [47, 257-259], one included adolescents [260], and three studies enrolled”
BackgroundZafirlukast Improves Asthma Control in Patients Receiving High-Dose Inhaled Corticosteroids
CHRISTIAN VIRCHOW, J., PRASSE, A., NAYA, I., SUMMERTON, L., HARRIS, A., & The Zafirlukast Study Group (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9905041 · Cited by 215
“Refractory” Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids
ten Brinke, A., Zwinderman, A. H., Sterk, P. J., Rabe, K. F., & Bel, E. H. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-440oc · Cited by 215
Self-citationRegular inhaled beta agonist in asthma: effects on exacerbations and lung function.
Taylor, D. R., Sears, M. R., Herbison, G. P., Flannery, E. M., Print, C. G., Lake, D. C., Yates, D. M., Lucas, M. K., & Li, Q. (1993) · Thorax · doi:10.1136/thx.48.2.134 · Cited by 212
Kaminska, M., Foley, S., Maghni, K., Storness-Bliss, C., Coxson, H., Ghezzo, H., Lemière, C., Olivenstein, R., Ernst, P., Hamid, Q., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.049 · Cited by 210 · cited 1×
“Second, autopsy and biopsy studies have linked an increased amount of airway smooth muscle to asthma severity, airflow obstruction and bronchial hyperresponsiveness [82, 117-120].”
BackgroundSelf-citationDifferences in Airway Cytokine Profile in Severe Asthma Compared to Moderate Asthma
Shannon, J., Ernst, P., Yamauchi, Y., Olivenstein, R., Lemiere, C., Foley, S., Cicora, L., Ludwig, M., Hamid, Q., & Martin, J. G. (2008) · Chest · doi:10.1378/chest.07-1881 · Cited by 209
Self-citationLemière, C., Ernst, P., Olivenstein, R., Yamauchi, Y., Govindaraju, K., Ludwig, M. S., Martin, J. G., & Hamid, Q. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.003 · Cited by 204 · cited 2×
“The mechanisms behind these diverse inflammatory profiles are likely complex, varied, and related to CS sensitivity [65, 66].”
BackgroundSelf-citationThe importance of nurse-led home visits in the assessment of children with problematic asthma
Bracken, M., Fleming, L., Hall, P., Van Stiphout, N., Bossley, C., Biggart, E., Wilson, N. M., & Bush, A. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.152140 · Cited by 202 · cited 5×
“Many children with asthma will also be found not to have severe, treatment-refractory asthma after a thorough evaluation [149] and approximately 50% of children referred for severe asthma have persistent symptoms and poor control because of inadequate disease management [148].”
BackgroundInfluentialSelf-citationFeatures of severe asthma in school-age children: Atopy and increased exhaled nitric oxide
Fitzpatrick, A. M., Gaston, B. M., Erzurum, S. C., & Teague, W. G. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.019 · Cited by 197 · cited 3×
“Children with severe asthma often have normal lung function and no acute response to bronchodilators [145].”
BackgroundSelf-citationPredictors of therapy resistant asthma: outcome of a systematic evaluation protocol
Heaney, L. G. (2003) · Thorax · doi:10.1136/thorax.58.7.561 · Cited by 192 · cited 2×
“Referral to a specialized centre where patients can undergo a systematic evaluation, resulted in 30-50% of patients previously called severe, being classed as difficult-to-control [141, 147, 148].”
BackgroundTranscriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma
Tsitsiou, E., Williams, A. E., Moschos, S. A., Patel, K., Rossios, C., Jiang, X., Adams, O.-D., Macedo, P., Booton, R., Gibeon, D., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.011 · Cited by 191
Self-citationLock, S. H., Kay, A. B., & Barnes, N. C. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564089 · Cited by 190
Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma
Lee, J. H., Haselkorn, T., Borish, L., Rasouliyan, L., Chipps, B. E., & Wenzel, S. E. (2007) · Chest · doi:10.1378/chest.07-0713 · Cited by 188 · cited 1×
“Prospective studies of lung function decline in severe asthma are limited, but suggest that male gender, smoking, increased FeNO and African ancestry are contributors, while interestingly, allergic status may be protective [104, 136].”
BackgroundSelf-citationDucharme, F. M., Lasserson, T. J., & Cates, C. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003137.pub3 · Cited by 186
Sputum inflammatory phenotypes are not stable in children with asthma
Fleming, L., Tsartsali, L., Wilson, N., Regamey, N., & Bush, A. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201064 · Cited by 186 · cited 1×
“This stability appears to be less in children [64].”
BackgroundSelf-citationPetsky, H. L., Cates, C. J., Li, A., Kynaston, J. A., Turner, C., & Chang, A. B. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006340.pub3 · Cited by 183
Chest Radiography and High Resolution Computed Tomography of the Lungs in Asthma
Paganin, F., Trussard, V., Seneterre, E., Chanez, P., Giron, J., Godard, P., Sénac, J. P., Michel, F. B., & Bousquet, J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.4.1084 · Cited by 181 · cited 2×
“Similarly, Paganin and colleagues reported two studies that investigated 13 and 37 patients with possible severe asthma (Aas score 4 or 5) and no particular selection criteria; the sampled population was also not described [161, 162].”
BackgroundSelf-citationKomakula, S., Khatri, S., Mermis, J., Savill, S., Haque, S., Rojas, M., Brown, L., Teague, G. W., & Holguin, F. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-32 · Cited by 178
Airway smooth muscle thickness in asthma is related to severity but not duration of asthma
James, A. L., Bai, T. R., Mauad, T., Abramson, M. J., Dolhnikoff, M., McKay, K. O., Maxwell, P. S., Elliot, J. G., & Green, F. H. (2009) · European Respiratory Journal · doi:10.1183/09031936.00181608 · Cited by 178 · cited 1×
“Second, autopsy and biopsy studies have linked an increased amount of airway smooth muscle to asthma severity, airflow obstruction and bronchial hyperresponsiveness [82, 117-120].”
BackgroundSelf-citationObesity and the lung: 4 {middle dot} Obesity and asthma
Sin, D. D., & Sutherland, E. R. (2008) · Thorax · doi:10.1136/thx.2007.086819 · Cited by 177 · cited 1×
“negatively on asthma control [218].”
Simon, M. R., Chinchilli, V. M., Phillips, B. R., Sorkness, C. A., Lemanske, R. F., Szefler, S. J., Taussig, L., Bacharier, L. B., & Morgan, W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.016 · Cited by 175
Increased Circulating Fibrocytes in Asthma with Chronic Airflow Obstruction
Wang, C.-H., Huang, C.-D., Lin, H.-C., Lee, K.-Y., Lin, S.-M., Liu, C.-Y., Huang, K.-H., Ko, Y.-S., Chung, K. F., & Kuo, H.-P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1557oc · Cited by 170 · cited 1×
“Finally, fibrocytes, which can differentiate into myofibroblasts, are increased in blood and in smooth muscle bundles in asthmatics with fixed airways obstruction and/or severe asthma [121, 122].”
BackgroundSelf-citationCorrelation of Systemic Superoxide Dismutase Deficiency to Airflow Obstruction in Asthma
Comhair, S. A. A., Ricci, K. S., Arroliga, M., Lara, A. R., Dweik, R. A., Song, W., Hazen, S. L., Bleecker, E. R., Busse, W. W., Chung, K. F., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200502-180oc · Cited by 169 · cited 1×
“dismutase and s-nitrosothiol depletion [105, 106].”
Self-citationDifferential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma
Simpson, J. L., Scott, R. J., Boyle, M., & Gibson, P. G. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-369oc · Cited by 169 · cited 1×
“This inflammation has been categorized into eosinophilic, neutrophilic, and/or paucigranulocytic [13, 28, 56-58].”
BackgroundSelf-citationPersistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma
Bousquet, J., Siergiejko, Z., Świebocka, E., Humbert, M., Rabe, K. F., Smith, N., Leo, J., Peckitt, C., Maykut, R., & Peachey, G. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02522.x · Cited by 168 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodDo Inhaled Corticosteroids Inhibit Growth in Children?
PEDERSEN, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2101050 · Cited by 164 · cited 1×
“while high doses of ICS are associated with an increased risk of adrenal suppression and growth retardation in children [213, 215-217].”
BackgroundFrey, U., & Suki, B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61450-6 · Cited by 164 · cited 1×
“Unbiased analyses are being applied to a broad range of clinical, physiologic and biologic characteristics, utilizing unsupervised hierarchical clustering stepwise discriminant and other approaches [11, 13, 24, 25].”
MethodSelf-citationSevere asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound
Vachier, I., Bonnans, C., Chavis, C., Farce, M., Godard, P., Bousquet, J. J., & Chanez, P. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.038 · Cited by 161 · cited 1×
“In this regard, severe asthma has been associated with lower levels of lipoxins, with their potential anti-inflammatory qualities, than patients with milder asthma [111-113].”
BackgroundSelf-citationBrinke, A. T., van Dissel, J. T., Sterk, P. J., Zwinderman, A. H., Rabe, K. F., & Bel, E. H. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.113047 · Cited by 160
Self-citationHolding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Cates, C. J., Crilly, J. A., & Rowe, B. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000052.pub2 · Cited by 160
Robinson, D. S., Campbell, D., & Barnes, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05113-8 · Cited by 159 · cited 1×
“adult asthmatics receiving LABA and ICS, some of whom are also on OCS, the addition of montelukast did not improve clinical outcomes over 14 days [243].”
BackgroundThe molecular phenotype of severe asthma in children
Fitzpatrick, A. M., Higgins, M., Holguin, F., Brown, L. A. S., & Teague, W. G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.01.048 · Cited by 159 · cited 2×
“Molecular phenotyping approaches are also emerging with data from severe asthmatic children suggesting Th1 skewing compared to those with moderate asthma, while a recent transcriptome analysis of peripheral blood cells suggested differential activation of CD8+ T-cells in severe asthma as compared to CD4+ T-cells [53,…”
ResultSelf-citationSlager, R. E., Otulana, B., Hawkins, G. A., Yen, Y. P., Peters, S. P., Wenzel, S. E., Meyers, D. A., & Bleecker, E. R. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.030 · Cited by 158
Self-citationEffect of Aerosolized Anti-IgE (E25) on Airway Responses to Inhaled Allergen in Asthmatic Subjects
FAHY, J. V., COCKCROFT, D. W., BOULET, L.-P., WONG, H. H., DESCHESNES, F., DAVIS, E. E., RUPPEL, J., SU, J. Q., & ADELMAN, D. C. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9810012 · Cited by 158 · cited 2×
“We reviewed all original publications from those reviews and additional RCTs we identified [268-283].”
MethodSelf-citationAirway Eosinophilia in Children with Severe Asthma: Predictive Values of Noninvasive Tests
Lex, C., Ferreira, F., Zacharasiewicz, A., Nicholson, A. G., Haslam, P. L., Wilson, N. M., Hansel, T. T., Payne, D. N. R., & Bush, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-352oc · Cited by 158 · cited 1×
“This inflammation has been categorized into eosinophilic, neutrophilic, and/or paucigranulocytic [13, 28, 56-58].”
BackgroundSelf-citationDaclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma
Busse, W. W., Israel, E., Nelson, H. S., Baker, J., Charous, B. L., Young, D. Y., Vexler, V. S., & Shames, R. S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1200oc · Cited by 158 · cited 2×
“Daclizumab, a humanised IgG1 monoclonal antibody against the IL-2Rα chain of activated lymphocytes improved FEV1 and asthma control in moderate-to-severe asthmatic adults inadequately controlled on ICS [325].”
BackgroundGoleva, E., Hauk, P. J., Hall, C. F., Liu, A. H., Riches, D. W. H., Martin, R. J., & Leung, D. Y. M. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.007 · Cited by 157
Fens, N., Roldaan, A. C., van der Schee, M. P., Boksem, R., Zwinderman, A. H., Bel, E. H., & Sterk, P. J. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03800.x · Cited by 153 · cited 1×
“Patterns of exhaled volatile organic compounds also differ between asthmatics with fixed airflow limitation and patients with COPD supporting their potential in the phenotyping of severe asthma [83, 84].”
BackgroundSelf-citationAlveolar macrophage phagocytosis is impaired in children with poorly controlled asthma
Fitzpatrick, A. M., Holguín, F., Teague, W. G., & Brown, L. A. S. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.008 · Cited by 152 · cited 1×
“Thus, macrophage phagocytosis of apoptotic epithelial cells or of bacteria has been reported to be impaired, which could lead to enhanced inflammation [95, 96].”
BackgroundSelf-citationHuynh, M.-L. N., Malcolm, K. C., Kotaru, C., Tilstra, J. A., Westcott, J. Y., Fadok, V. A., & Wenzel, S. E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-035oc · Cited by 151
Self-citationAn Integrative Systems Biology Approach to Understanding Pulmonary Diseases
Auffray, C., Adcock, I. M., Chung, K. F., Djukanović, R., Pison, C. M., & Sterk, P. J. (2010) · CHEST Journal · doi:10.1378/chest.09-1850 · Cited by 151 · cited 1×
“Unbiased analyses are being applied to a broad range of clinical, physiologic and biologic characteristics, utilizing unsupervised hierarchical clustering stepwise discriminant and other approaches [11, 13, 24, 25].”
MethodSelf-citationThe outer wall of small airways is a major site of remodeling in fatal asthma
Dolhnikoff, M., da Silva, L. F. F., Araujo, B., Gomes, H. A. P., Fernezlian, S., Mulder, A., Lindeman, J. H. N., & Mauad, T. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.032 · Cited by 148 · cited 1×
“Patients with severe asthmatics also have increased expression of TGF-β isoforms and collagen deposition as compared to mild asthmatics, again in association with eosinophilic asthma, with evidence for remodelling in the peripheral airways as well [28, 125].”
BackgroundSelf-citationExhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Fens, N., de Nijs, S. B., Peters, S. P., Dekker, T., Knobel, H., Vink, T. J., Willard, N. P., Zwinderman, A. H., Krouwels, F. H., Janssen, H., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00032911 · Cited by 146 · cited 1×
“Patterns of exhaled volatile organic compounds also differ between asthmatics with fixed airflow limitation and patients with COPD supporting their potential in the phenotyping of severe asthma [83, 84].”
BackgroundSelf-citationStirling, R. G., Kharitonov, S. A., Campbell, D. A., Robinson, D. S., Durham, S. R., Chung, K. F., & Barnes, P. J. (1998) · Thorax · doi:10.1136/thx.53.12.1030 · Cited by 146
Self-citation
Cited by
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
“Oropharyngeal pain 15 (8) 12 (6) 7 (4)”
Self-citationPapi, A., Brightling, C., Pedersen, S. E., & Reddel, H. K. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33311-1 · Cited by 1,759
Self-citationOral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Self-citationBleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
Self-citationFitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
Self-citation
Metadata
- Authors
- Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., Boulet, L.-P., Brightling, C., Chanez, P., Dahlen, S.-E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jarjour, N. N., Mauad, T., Sorkness, R. L., & Teague, W. G.
- Affiliations
- Royal Brompton Hospital (GB)
- University of Pittsburgh (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Imperial College London (GB)
- University of Cape Town (ZA)
- Wake Forest University (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- University of Leicester (GB)
- Aix-Marseille Université (FR)
- Karolinska Institutet (SE)
- University of Basel (CH)
- John Hunter Hospital (AU)
- McGill University (CA)
- University of Wisconsin System (US)
- University of Virginia (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2013-12-12
- Volume
- 43
- Issue
- 2
- Pages
- 343-373
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2098276532
- Cited by
- 3,926
- References
- 321
- Citations by year
- 2026: 204 · 2025: 296 · 2024: 347 · 2023: 335 · 2022: 370 · 2021: 404 · 2020: 425 · 2019: 397 · 2018: 339 · 2017: 315 · 2016: 224 · 2015: 174 · 2014: 85 · 2013: 2
- FWCI
- 112.27
- Type
- journal article
- Language
- en
- Update notices
- Open access
- closed
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10192, NF-SI-0512-10018, NF-SI-0509-10080)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- severe asthma, therapy-resistant asthma, asthma phenotypes, eosinophilic asthma, exhaled nitric oxide, anti-IgE, methotrexate, macrolide antibiotics, antifungal agents, bronchial thermoplasty, high-dose inhaled corticosteroids, systemic corticosteroids, asthma phenotyping, biomarkers, children and adults
- MeSH terms
- Adrenal Cortex Hormones, Asthma, Clinical Trials as Topic, Humans, Immunoglobulin E, Immune System, International Cooperation, Phenotype, Risk Factors, Pulmonary Medicine, Biomarkers, Comorbidity, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.